Lunai Bioworks Signs Master Collaboration Agreement With BrainStorm Therapeutics; BioSymetrics Publishes Parkinson's Disease AI White Paper, Initial Data Expected In 1H 2027

8-K filing — BRAINSTORM CELL THERAPEUTICS INC. (BCLI)

Filed: 2026-08-14 AccNo: 0001104659-26-097180 Size: 281 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Brainstorm Cell Q2 EPS $(0.35) Down From $(0.34) YoY

Brainstorm Cell (OTC:BCLI) reported quarterly losses of $(0.35) per share. This is a 2.94 percent decrease over losses of $(0.34) per share from the same period last year.

Lunai Bioworks Files Second Amended Complaint Against Six Registered Broker-Dealers And Two Broker-Dealer Principals As Defendants In U.S. District Court, Delaware

Lunai Bioworks Files Amended RICO Complaint Expanding Naked Short-Selling Lawsuit; Names 10 Defendants, Including 3 FINRA Registered Broker Dealers, In Connection With An Alleged Coordinated Naked Short Selling Scheme That The Company Says Generated Failures To Deliver On More Than 81% Of Its Outstanding Shares

Amended Complaint Alleges 29.6 Million Failed to Deliver Shares and Single Day Trading Volume of 15.3 Times Shares Outstanding, Company Seeks Treble Damages Under Federal RICO StatuteWILMINGTON, Del. and SACRAMENTO,

8-K filing — Lunai Bioworks Inc. (LNAI)

Filed: 2026-06-17 AccNo: 0001731122-26-000871 Size: 211 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits